• Margaret R Bauer, Tracy Shamas, Sarah Gillespie-Heyman, and Andrea Ruskin.
• VA Connecticut Healthcare System, West Haven, Connecticut, USA. Electronic address: margaret.bauer@va.gov.
• J Pain Symptom Manage. 2021 Aug 1; 62 (2): 410-415.

BackgroundNo guidelines for safe opioid prescribing in palliative care exist, which contributes to limited monitoring of opioid misuse in palliative care.MeasuresFeasibility of a safe opioid prescribing standard operating protocol (SOP) was determined by assessing the percentage of patients in an outpatient cancer center who completed each component of a five-component SOP.InterventionA five-component SOP included: risk stratification for misuse, consent form, prescription drug monitoring program review, urine drug testing, and Naloxone for high-risk individuals.OutcomesAfter one year, compliance rates on four of the of the five-component SOP were greater or equal to 93%. Naloxone co-prescription for high-risk patients never reached over 78%, largely due to clinical decision not to co-prescribe if transition to hospice was imminent.Conclusions/Lessons LearnedSafe opioid prescribing measures are feasible in outpatient palliative care and can facilitate identification of individuals at risk for opioid misuse and prompt early interventions for misuse.Published by Elsevier Inc.

17 keywords...

hide…